“Biophotonics is the science of utilizing photonic activity within tissue to detect, diagnose and treat diseases in a way that is non-invasive to the body. We were early pioneers in this field and our new name, Advanced BioPhotonics Inc., better defines the nature of our core medical imaging technology. We believe that it will further enhance our visibility within the medical and biomedical imaging marketplace,” said Denis O’Connor, president and CEO. “This name change also symbolizes the transformation the company is undergoing as we progress from a research and development-stage company to a commercial organization.”
Advanced BioPhotonics develops functional medical imaging applications using infrared focal plane arrays.
New ticker symbol for AMO
Advanced Medical Optics (AMO; Santa Ana, California), reported that, effective June 8, shares of its common stock began trading on the New York Stock Exchange under the new ticker symbol EYE.
AMO is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery.